Home » Archive by Month

Article Archive for October 2009

Not a Pretty Picture: Debt, Divorce, and Bankruptcy
10/30/2009 – 1:42 pm PDT | No Comment

Those were the top named service requests reported by Pre-Paid Legal Services (NYSE: PPD) based on input from their participating law firms.  Pre-paid legal services provides specified legal services to their members.

Rosetta Genomics’ Diagnostic Program Update (NASDAQ:ROSG)
10/30/2009 – 1:37 pm PDT | No Comment

Rosetta Genomics (NASDAQ:ROSG) today announced an update regarding their colon cancer diagnostic program and said that Ayelet Chajut, Executive Vice President, R&D, Head of Molecular Biology will speak more about this program at the 6th …

Geron Will Re-initiate Clinical Trials (NASDAQ:GERN)
10/30/2009 – 1:22 pm PDT | No Comment

Geron Corporation (NASDAQ:GERN) today announced that they have reached an agreements with the Food and Drug Administration to re-initiate clinical trials for spinal cord injury.

BSD Medical’s Hyperthermia Therapy (NASDAQ:BSDM)
10/30/2009 – 12:25 pm PDT | No Comment

BSD Medical Corporation (NASDAQ:BSDM) today announced that their published study results demonstrated improvement in the overall survival, tumor response rates, and local tumor control from the addition of hyperthermia therapy delivered through BSD-2000 Hyperthermia System. …

NavStar Technologies Fails To Meet Promises (PINK:NVSR)
10/30/2009 – 9:34 am PDT | No Comment

It has been almost a month since NavStar Technologies Inc (PINK:NVSR) announced a “Major Breakthrough” in the Middle east on October 8, 2009. They anounced that “Details will be provided to shareholders in the next 5 to …

Depomed Q3 Financial Results (NASDAQ:DEPO)
10/30/2009 – 7:33 am PDT | No Comment

Depomed, Inc (NASDAQ:DEPO) today reported financial results for the third quarter that ended on September 30, 2009.

Dynavax with new HEPLISAV Data (NASDAQ:DVAX)
10/30/2009 – 7:15 am PDT | No Comment

In one of the most surprising news today, Dynavax Technologies Corporation (NASDAQ:DVAX) has announced that the first clinical data of their HEPLISAV has shown increase in the protection rate for chronic kidney disease patients. The data …

Celera and Medical Therapies (NASDAQ:CRA)
10/30/2009 – 7:00 am PDT | No Comment

On a late Thursday evening, Celera Corporation (NASDAQ:CRA) and Medical Therapies Limited have announced that they have entered an exclusive license agreement for the use of Medical Therapies’ midkine patent portfolio for the development of …